BRIEF-Genmab says first Cd38 monoclonal antibody approved in Europe
May 23, 2016 at 07:35 AM EDT
* Announces European conditional marketing authorization for Darzalex(r) (daratumumab) for multiple myeloma
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.